In the past week, SCLX stock has gone down by -5.51%, with a monthly decline of -30.35% and a quarterly plunge of -46.43%. The volatility ratio for the week is 16.25%, and the volatility levels for the last 30 days are 14.40% for Scilex Holding Company The simple moving average for the past 20 days is -24.68% for SCLX’s stock, with a -51.93% simple moving average for the past 200 days.
Is It Worth Investing in Scilex Holding Company (NASDAQ: SCLX) Right Now?
The 36-month beta value for SCLX is also noteworthy at 0.97. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for SCLX is 128.69M, and at present, short sellers hold a 8.58% of that float. The average trading volume of SCLX on November 26, 2024 was 1.93M shares.
SCLX) stock’s latest price update
Scilex Holding Company (NASDAQ: SCLX) has experienced a rise in its stock price by 15.21 compared to its previous closing price of 0.52. However, the company has seen a fall of -5.51% in its stock price over the last five trading days. globenewswire.com reported 2024-11-22 that PALO ALTO, Calif., Nov. 22, 2024 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today reported that it received a notice (the “Notice”) on November 21, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that it was not in compliance with Nasdaq’s continued listing requirements under the Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) as a result of its failure to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the “Q3 Form 10-Q”) in a timely manner.
Analysts’ Opinion of SCLX
Many brokerage firms have already submitted their reports for SCLX stocks, with Alliance Global Partners repeating the rating for SCLX by listing it as a “Buy.” The predicted price for SCLX in the upcoming period, according to Alliance Global Partners is $14 based on the research report published on October 16, 2024 of the current year 2024.
Rodman & Renshaw, on the other hand, stated in their research note that they expect to see SCLX reach a price target of $13. The rating they have provided for SCLX stocks is “Buy” according to the report published on June 13th, 2024.
B. Riley Securities gave a rating of “Buy” to SCLX, setting the target price at $4 in the report published on October 16th of the previous year.
SCLX Trading at -30.10% from the 50-Day Moving Average
After a stumble in the market that brought SCLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -77.19% of loss for the given period.
Volatility was left at 14.40%, however, over the last 30 days, the volatility rate increased by 16.25%, as shares sank -38.93% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -44.95% lower at present.
During the last 5 trading sessions, SCLX fell by -5.51%, which changed the moving average for the period of 200-days by -63.41% in comparison to the 20-day moving average, which settled at $0.7966. In addition, Scilex Holding Company saw -70.59% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SCLX starting from Ji Henry, who purchase 8,888 shares at the price of $0.94 back on Oct 31 ’24. After this action, Ji Henry now owns 320,161 shares of Scilex Holding Company, valued at $8,351 using the latest closing price.
SHAH JAISIM, the of Scilex Holding Company, purchase 32,000 shares at $0.99 during a trade that took place back on Oct 29 ’24, which means that SHAH JAISIM is holding 109,333 shares at $31,670 based on the most recent closing price.
Stock Fundamentals for SCLX
Current profitability levels for the company are sitting at:
- -1.95 for the present operating margin
- 0.64 for the gross margin
The net margin for Scilex Holding Company stands at -2.34. The total capital return value is set at 0.66.
Based on Scilex Holding Company (SCLX), the company’s capital structure generated -0.95 points at debt to capital in total, while cash flow to debt ratio is standing at 0.12. The debt to equity ratio resting at -0.49. The interest coverage ratio of the stock is -45.77.
Currently, EBITDA for the company is -109.1 million with net debt to EBITDA at -0.89. When we switch over and look at the enterprise to sales, we see a ratio of 4.23. The receivables turnover for the company is 1.34for trailing twelve months and the total asset turnover is 0.49. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.20.
Conclusion
In summary, Scilex Holding Company (SCLX) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
